Indefinite Delivery Contract SPE2DX15D1109

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This IDC enables efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism. The contract has a period of performance through December 31, 2025 and did not utilize any set-aside requirements, indicating open competition.

The IDC is supplemented by numerous delivery orders issued against it, with over 40 task orders reviewed from August 2020. These delivery orders cover a diverse array of pharmaceutical and medical products, ranging from specialty medications to generic drugs, syringes, vials, and other critical care items. The task orders, all awarded on a firm-fixed-price basis, were issued by the DLA Troop Support Medical and had completion dates in August and September 2020, with ceiling values varying from a few dollars to over $29,000. The place of performance for these task orders was consistently Chesterbrook, Pennsylvania, where Amerisourcebergen's distribution facilities are located.